Angel Biotechnology Holdings (LSE:ABH) Net Margin %: -267.48% (As of Sep. 2012)


What is Angel Biotechnology Holdings Net Margin %?

Angel Biotechnology Holdings LSE:ABH Net Margin % is -267.48% as of Sep. 2012. The stock has 2 warning signs investors should review.

Net margin is calculated as Net Income divided by its Revenue. Angel Biotechnology Holdings's Net Income for the six months ended in Sep. 2012 was £-2.86 Mil. Angel Biotechnology Holdings's Revenue for the six months ended in Sep. 2012 was £1.07 Mil. Therefore, Angel Biotechnology Holdings's net margin for the quarter that ended in Sep. 2012 was -267.48%.

The historical rank and industry rank for Angel Biotechnology Holdings's Net Margin % or its related term are showing as below:

LSE:ABH' s Net Margin % Range Over the Past 10 Years
Min: -272.7   Med: -59.9   Max: 6.6
Current: -37.6

LSE:ABH's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -89.33 vs LSE:ABH: -37.60

Angel Biotechnology Holdings  (LSE:ABH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Angel Biotechnology Holdings Net Margin % Related Terms

Angel Biotechnology Holdings Net Margin % Historical Data

* Premium members only.

The historical data trend for Angel Biotechnology Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angel Biotechnology Holdings Net Margin % Chart

Angel Biotechnology Holdings Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec07 Dec08 Dec09 Dec10 Mar12
Net Margin %
Get a 7-Day Free Trial Premium Member Only -272.69 -113.85 -51.08 6.55 -37.59

Angel Biotechnology Holdings Semi-Annual Data
Jun05 Dec05 Jun06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Mar12 Sep12
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.31 5.82 -17.19 0.00 -267.48

Angel Biotechnology Holdings Net Margin % Competitor Comparison

For the Biotechnology subindustry, Angel Biotechnology Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Angel Biotechnology Holdings Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Angel Biotechnology Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Angel Biotechnology Holdings's Net Margin % falls into.


Angel Biotechnology Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Angel Biotechnology Holdings's Net Margin for the fiscal year that ended in Mar. 2012 is calculated as

Net Margin=Net Income (A: Mar. 2012 )/Revenue (A: Mar. 2012 )
=-1.299/3.456
=-37.59 %

Angel Biotechnology Holdings's Net Margin for the quarter that ended in Sep. 2012 is calculated as

Net Margin=Net Income (Q: Sep. 2012 )/Revenue (Q: Sep. 2012 )
=-2.862/1.07
=-267.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -267.48% mean?
Angel Biotechnology Holdings (LSE:ABH) has a Net Margin % of -267.48% as of Sep. 2012. Net margin is the ratio of total net income to net sales. View historical data on Angel Biotechnology Holdings and its competitors.
Is Angel Biotechnology Holdings' Net Margin % too high?
Angel Biotechnology Holdings' current Net Margin % is -267.48%.
How does Angel Biotechnology Holdings' Net Margin % compare to competitors?
Angel Biotechnology Holdings' Net Margin % of -267.48% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Angel Biotechnology Holdings and its competitors. Angel Biotechnology Holdings's current Net Margin % is -267.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angel Biotechnology Holdings stock overvalued right now?
Angel Biotechnology Holdings (LSE:ABH) has a current Net Margin % of -267.48%. The current Net Margin % is -267.48%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Angel Biotechnology Holdings (LSE:ABH), the current Net Margin % is -267.48% as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.